THERAVECTYS
🏢 View company profile →9Patents
9Active
9Granted
44Portfolio score
Filing activity: Aug 1, 2008 → Jul 20, 2017 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8420104B2 | Lentiviral gene transfer vectors and their medicinal applications | Emerging Cross-Sectional Technologies | 8 | Active |
| US10752668B2 | Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule | Chemistry; Metallurgy | 4 | Active |
| US9657311B2 | Lentiviral vectors containing an MHC class I, MHC class II, or B2 microglobulin upstream promoter sequence | Chemistry; Metallurgy | 3 | Active |
| US8709799B2 | Lentiviral gene transfer vectors and their medicinal applications | Emerging Cross-Sectional Technologies | 1 | Active |
| US9328146B2 | Lentiviral gene transfer vectors and their medicinal applications | Emerging Cross-Sectional Technologies | 1 | Active |
| US9987351B2 | Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1 | Chemistry; Metallurgy | 0 | Active |
| US8951535B2 | Lentiviral vectors containing an MHC class I promoter | Chemistry; Metallurgy | 0 | Active |
| US9752160B2 | Use of non-subtype B gag proteins for lentiviral packaging | Chemistry; Metallurgy | 0 | Active |
| US10864265B2 | Lentiviral vectors for expression of hepatitis B virus (HBV) antigens | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.